Market Overview:
The global stem cell therapy for diabetes and related conditions market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The market growth can be attributed to factors such as rising prevalence of diabetes, increasing awareness about stem cell therapy, and technological advancements in the field of stem cell therapy. Based on type, the global stem cell therapy for diabetes and related conditions market is segmented into monotherapy and combination therapy. Monotherapy is further sub-segmented into allogeneic monotherapy and autologous monotherapy. Combination therapy is further sub-segmented into syngeneic combination therapy and xenogeneic combination therapy. Based on application, the global stem cell Therapy for Diabetes And Related Conditions Market is segmented into type 1 diabetes mellitus, type 2 diabetes mellitus, diabetic foot ulcer, diabetic nephropathy, diabetic neuropathy among others. North America dominates the global Stem Cell Therapy For Diabetes And Related Conditions Market followed by Europe due to high prevalence of chronic diseases such as obesity & hypertension in these regions which leads to an increase in number of people suffering from Type 2 Diabetes Mellitus (T2DM).
Product Definition:
stem cell therapy is the use of stem cells to treat or prevent a disease or condition.
Monotherapy:
Monotherapy is a treatment method that requires only one drug or medication for the management of a disease. Monotherapy can be used in cases where there are no effective medications available for the treatment of diabetes and related conditions. The primary purpose of using monotherapy is to reduce or eliminate the need for insulin in patients suffering from diabetes mellitus, thus reducing adverse effects associated with it such as hypoglycemia and hyperglycemia.
Combination Therapy:
Combination therapy is a medication used in the treatment of diseases that are not responsive to conventional treatments. In such cases, combination therapies include two or more drugs or medications that are used together and they act in a synergistic manner. The major driving factor for this market is the rising prevalence of diabetes and related conditions globally due to unhealthy eating habits, lack of exercise, obesity, and other factors.
Application Insights:
Based on application, the global market is segmented into type 1 diabetes mellitus, type 2 diabetes mellitus and diabetic foot ulcer, diabetic nephropathy, and diabetic neuropathy. In 2017, the diabetic foot ulcer segment dominated the market with a share of over 40% in terms of revenue. This high share is attributable to increasing cases of hospital-acquired Diabetic Foot Ulcers (DFUs) which are a result of failure to manage blood glucose levels in patients suffering from Diabetes Mellitus. As per data published by WHO in 2018 regarding DFUs globally; around 10 million people suffer from DFUs every year with Germany recording one of the highest incidences rate globally.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a large number of industry players, high awareness levels about stem cell therapy and availability of effective reimbursement policies for treatment. The U.S., which is at the forefront, accounted for more than 80% share in North America owing to an increase in funding from public agencies such as National Institute of Health (NIH) and support from government entities such as FDA and EMA that have approved several clinical trials pertaining to use of adult stem cells for treatment or research purposes.
Asia Pacific is expected to witness lucrative growth over the forecast period due to increasing cases diabetes coupled with rising investments by private companies seeking approval from regulatory authorities for commercialization their products within region or globally.
Growth Factors:
- Increasing prevalence of diabetes and other chronic diseases
- Rising public awareness about the benefits of stem cell therapy
- Growing demand for minimally invasive treatments
- Technological advancements in stem cell therapy treatment methods 5. increasing investment in research and development
Scope Of The Report
Report Attributes
Report Details
Report Title
Stem Cell Therapy for Diabetes and Related Conditions Market Research Report
By Type
Monotherapy, Combination Therapy
By Application
Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus, Diabetic Foot Ulcer, Diabetic Nephropathy, Diabetic Neuropathy
By Companies
Athersys, Mesoblast, Caladrius Biosciences, Sanofi, Novo Nordisk
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
194
Number of Tables & Figures
136
Customization Available
Yes, the report can be customized as per your need.
Global Stem Cell Therapy for Diabetes and Related Conditions Market Report Segments:
The global Stem Cell Therapy for Diabetes and Related Conditions market is segmented on the basis of:
Types
Monotherapy, Combination Therapy
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus, Diabetic Foot Ulcer, Diabetic Nephropathy, Diabetic Neuropathy
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Athersys
- Mesoblast
- Caladrius Biosciences
- Sanofi
- Novo Nordisk
Highlights of The Stem Cell Therapy for Diabetes and Related Conditions Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Monotherapy
- Combination Therapy
- By Application:
- Type 1 Diabetes Mellitus
- Type 2 Diabetes Mellitus
- Diabetic Foot Ulcer
- Diabetic Nephropathy
- Diabetic Neuropathy
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Stem Cell Therapy for Diabetes and Related Conditions Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Stem cell therapy is a treatment that uses stem cells to help improve the health of people with diabetes and related conditions. Stem cells can help restore damaged tissues in the body, which may help improve blood sugar control and other symptoms of diabetes.nnThere are several types of stem cell therapies that are being studied for use in treating diabetes and related conditions. Some examples include:nnu2022 Stem cell transplantation u2013 This type of therapy involves using stem cells from a donor to treat someone with diabetes or another condition. The donated stem cells may be used to replace damaged tissue in the body or to boost the immune system, which could lead to improved blood sugar control. There is still some research needed before this type of therapy can be used safely and effectively in people with diabetes.nnu2022 Gene Therapy u2013 This approach uses genetic instructions (called genes) to change how a personu2019s own cells behave. In studies so far, gene therapy has been successful at restoring insulin production by pancreatic beta-cells (a type of cell involved in controlling blood sugar). However, there is still much more research needed before gene therapy can be considered as an effective treatment for Diabetes Mellitus Type 2 or any other form of Diabetes mellitus .
Some of the major companies in the stem cell therapy for diabetes and related conditions market are Athersys, Mesoblast, Caladrius Biosciences, Sanofi, Novo Nordisk.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Stem Cell Therapy for Diabetes and Related Conditions Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Stem Cell Therapy for Diabetes and Related Conditions Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Stem Cell Therapy for Diabetes and Related Conditions Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Stem Cell Therapy for Diabetes and Related Conditions Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Stem Cell Therapy for Diabetes and Related Conditions Market Size & Forecast, 2018-2028
4.5.1 Stem Cell Therapy for Diabetes and Related Conditions Market Size and Y-o-Y Growth
4.5.2 Stem Cell Therapy for Diabetes and Related Conditions Market Absolute $ Opportunity
Chapter 5 Global Stem Cell Therapy for Diabetes and Related Conditions Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Stem Cell Therapy for Diabetes and Related Conditions Market Size Forecast by Type
5.2.1 Monotherapy
5.2.2 Combination Therapy
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Stem Cell Therapy for Diabetes and Related Conditions Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Stem Cell Therapy for Diabetes and Related Conditions Market Size Forecast by Applications
6.2.1 Type 1 Diabetes Mellitus
6.2.2 Type 2 Diabetes Mellitus
6.2.3 Diabetic Foot Ulcer
6.2.4 Diabetic Nephropathy
6.2.5 Diabetic Neuropathy
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Stem Cell Therapy for Diabetes and Related Conditions Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Stem Cell Therapy for Diabetes and Related Conditions Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Stem Cell Therapy for Diabetes and Related Conditions Analysis and Forecast
9.1 Introduction
9.2 North America Stem Cell Therapy for Diabetes and Related Conditions Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Stem Cell Therapy for Diabetes and Related Conditions Market Size Forecast by Type
9.6.1 Monotherapy
9.6.2 Combination Therapy
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Stem Cell Therapy for Diabetes and Related Conditions Market Size Forecast by Applications
9.10.1 Type 1 Diabetes Mellitus
9.10.2 Type 2 Diabetes Mellitus
9.10.3 Diabetic Foot Ulcer
9.10.4 Diabetic Nephropathy
9.10.5 Diabetic Neuropathy
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Stem Cell Therapy for Diabetes and Related Conditions Analysis and Forecast
10.1 Introduction
10.2 Europe Stem Cell Therapy for Diabetes and Related Conditions Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Stem Cell Therapy for Diabetes and Related Conditions Market Size Forecast by Type
10.6.1 Monotherapy
10.6.2 Combination Therapy
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Stem Cell Therapy for Diabetes and Related Conditions Market Size Forecast by Applications
10.10.1 Type 1 Diabetes Mellitus
10.10.2 Type 2 Diabetes Mellitus
10.10.3 Diabetic Foot Ulcer
10.10.4 Diabetic Nephropathy
10.10.5 Diabetic Neuropathy
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Stem Cell Therapy for Diabetes and Related Conditions Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Stem Cell Therapy for Diabetes and Related Conditions Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Stem Cell Therapy for Diabetes and Related Conditions Market Size Forecast by Type
11.6.1 Monotherapy
11.6.2 Combination Therapy
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Stem Cell Therapy for Diabetes and Related Conditions Market Size Forecast by Applications
11.10.1 Type 1 Diabetes Mellitus
11.10.2 Type 2 Diabetes Mellitus
11.10.3 Diabetic Foot Ulcer
11.10.4 Diabetic Nephropathy
11.10.5 Diabetic Neuropathy
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Stem Cell Therapy for Diabetes and Related Conditions Analysis and Forecast
12.1 Introduction
12.2 Latin America Stem Cell Therapy for Diabetes and Related Conditions Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Stem Cell Therapy for Diabetes and Related Conditions Market Size Forecast by Type
12.6.1 Monotherapy
12.6.2 Combination Therapy
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Stem Cell Therapy for Diabetes and Related Conditions Market Size Forecast by Applications
12.10.1 Type 1 Diabetes Mellitus
12.10.2 Type 2 Diabetes Mellitus
12.10.3 Diabetic Foot Ulcer
12.10.4 Diabetic Nephropathy
12.10.5 Diabetic Neuropathy
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Stem Cell Therapy for Diabetes and Related Conditions Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Stem Cell Therapy for Diabetes and Related Conditions Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Stem Cell Therapy for Diabetes and Related Conditions Market Size Forecast by Type
13.6.1 Monotherapy
13.6.2 Combination Therapy
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Stem Cell Therapy for Diabetes and Related Conditions Market Size Forecast by Applications
13.10.1 Type 1 Diabetes Mellitus
13.10.2 Type 2 Diabetes Mellitus
13.10.3 Diabetic Foot Ulcer
13.10.4 Diabetic Nephropathy
13.10.5 Diabetic Neuropathy
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Stem Cell Therapy for Diabetes and Related Conditions Market: Competitive Dashboard
14.2 Global Stem Cell Therapy for Diabetes and Related Conditions Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Athersys
14.3.2 Mesoblast
14.3.3 Caladrius Biosciences
14.3.4 Sanofi
14.3.5 Novo Nordisk
